netFormulary South Warwickshire NHS
NHS Foundation Trust  
 Introduction
Welcome to South Warwickshire NHS Foundation Trust Formulary

Useful Links

 

Coventry and Warwickshire

APC Formulary 

APC image

 

South Warwickshire NHS Foundation Trust

 
 

SWFT Medicines Management Intranet page

SWFT Medicines Management Intranet page

 

 

 

MEDUSA Injectable Medicines Administration guide  

View childrens BNF 

View SPC online 

View adult BNF 

 

DA1 - New Medicines Request application 
 

 

 

   

   

 

News Feed

DTC February 2018 - Papers that were approved include:- Sickle Cell SOP.  Approved new drugs include Ustekinumab injection for Chrohn's and Beclometasone/formoterol/glycopyrronium inhaler Trimbow.


DTC January 2018 - Papers that were approved include:- Tinzaparin injection PGD and Pertussis Vaccine PGD.  New drugs that were approved include Sarilumab for rheumatoid arthritis, Guselkumab for chronic plaque psoriasis and Akynzeo® (netupitan + palonosetron) for prevention of acute and delayed nausea and vomiting associated with chemotherapy.


DTC December 2017 - Approved documents were Sepsis (Suspected or Confirmed) Management in Pregnancy and the Puerperium, Outpatient Parenteral Antimicrobial Therapy (OPAT) team Linezolid Patient Information Leaflet and Paracetamol Overdose SOP.
November 2017 - Updates to Bisphosphonate guidelines, Hypomagnesaemia Management guidelines, Neonatal Oral Medication Administration in the Maternity Unit guideline and Intrathecal Cytotoxic Chemotherapy Policy were approved. New drug Baricitinib was approved for use for rheumatology Homecare patients.
October 2017 - New products that were approved for inclusion on the Formulary include:- Insulin Aspart (Fiasp)

>>> more news

South Warwickshire NHS Foundation Trust 

The main aim of this formulary is to promote safe, evidence-based, cost-effective prescribing.

Limiting the range of medicines included in the formulary and promoting the use of generic medicines where appropriate:-

  • Enhances safety through familiarity with the medicines in use in the hospital by all staff
    involved in the prescribing, dispensing and administration of medicines
  • Ensures efficient use of NHS resources
  • Ensures efficient use of limited storage space both within the hospital pharmacies and
    on the wards, enhances good stock control and reduces the pharmacy stock holding

Streamlining medicines choices in line with our local Area Prescribing committee also ensures appropriate and equitable use of medicines across the local health economy. 

The introduction of new medicines to the medicines formulary is managed by the SWFT Drugs and Therapeutics Committee.

The DTC meets monthly and members (consultants, pharmacists, nurses and GP's) come from the Trust and the host clinical commissioning group.

Positive NICE technology appraisals

Medicines which have been granted a positive technology appraisal by the National Institute for Health and Clinical Excellence (NICE) have been automatically included in our local formulary.

We are compliant with the 90 day window given to include a medicine with a positive NICE technology appraisal in our formulary.

Proposals to include other medicines require a consultant to make a submission to the pharmacy department.  Requests for inclusion of new medicines should be discussed with the specialty pharmacist and a DA1 application completed: DA1 Form


NetFormulary
   Last updated: 22/09/2020 09:43:52.
    Download net formulary from Apple IOS Store  Google Play net formulary